Intellipharmaceutics International Inc. Quarterly Liabilities and Equity in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Intellipharmaceutics International Inc. quarterly Liabilities and Equity history and growth rate from Q4 2010 to Q3 2023.
  • Intellipharmaceutics International Inc. Liabilities and Equity for the quarter ending August 31, 2023 was $1.57M, a 8.96% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $1.57M +$129K +8.96% Aug 31, 2023 6-K 2023-10-16
Q2 2023 $1.74M -$146K -7.77% May 31, 2023 6-K 2023-09-26
Q1 2023 $1.6M -$294K -15.6% Feb 28, 2023 6-K 2023-09-26
Q4 2022 $1.43M -$664K -31.7% Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $1.44M -$2.02M -58.4% Aug 31, 2022 6-K 2022-10-14
Q2 2022 $1.88M -$3.1M -62.2% May 31, 2022 6-K 2022-07-21
Q1 2022 $1.89M -$793K -29.6% Feb 28, 2022 6-K 2022-04-14
Q4 2021 $2.1M -$1.29M -38.1% Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $3.46M -$760K -18% Aug 31, 2021 6-K 2021-10-15
Q2 2021 $4.98M +$1.42M +39.7% May 31, 2021 6-K 2021-07-15
Q1 2021 $2.68M -$920K -25.5% Feb 28, 2021 6-K 2021-04-14
Q4 2020 $3.39M -$410K -10.8% Nov 30, 2020 20-F/A 2022-05-09
Q3 2020 $4.22M +$54.6K +1.31% Aug 31, 2020 6-K 2020-10-15
Q2 2020 $3.56M -$2M -36% May 31, 2020 6-K 2020-07-15
Q1 2020 $3.6M -$3.95M -52.3% Feb 29, 2020 6-K 2020-05-29
Q4 2019 $3.8M -$7.68M -66.9% Nov 30, 2019 20-F 2021-03-31
Q3 2019 $4.16M -$1.47M -26.1% Aug 31, 2019 6-K 2019-10-11
Q2 2019 $5.57M -$1.1M -16.5% May 31, 2019 6-K 2019-07-10
Q1 2019 $7.55M Feb 28, 2019 6-K 2019-04-15
Q4 2018 $11.5M +$4.08M +55.1% Nov 30, 2018 20-F 2020-03-30
Q3 2018 $5.63M Aug 31, 2018 6-K 2018-10-15
Q2 2018 $6.67M May 31, 2018 6-K/A 2018-07-24
Q4 2017 $7.4M Nov 30, 2017 6-K 2018-10-15
Q4 2015 $5.22M -$2.65M -33.7% Nov 30, 2015 20-F 2016-03-21
Q4 2014 $7.88M +$3.5M +79.8% Nov 30, 2014 20-F 2016-03-21
Q1 2014 $10.5M Feb 28, 2014 6-K 2014-04-14
Q4 2013 $4.38M +$1.9M +77% Nov 30, 2013 20-F 2015-02-27
Q4 2012 $2.47M -$3.77M -60.4% Nov 30, 2012 20-F 2014-02-18
Q4 2011 $6.25M +$2.98M +91.2% Nov 30, 2011 20-F/A 2013-02-01
Q4 2010 $3.27M Nov 30, 2010 20-F 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.